PHENYLEPHRINE HYDROCHLORIDE (phenylephrine hydrochloride) by Aspiro Therapeutics is alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. First approved in 2013.
Drug data last refreshed 19h ago · AI intelligence enriched 4d ago
Phenylephrine hydrochloride is an alpha-1 adrenergic receptor agonist ophthalmic solution used for pupil dilation (mydriasis) in diagnostic and therapeutic eye procedures. It works by constricting ophthalmic blood vessels and contracting the radial iris muscle, producing vasoconstriction and mydriatic effects. This is a mature, well-established product in the ophthalmology space.
Peak-stage product with minimal competitive pressure suggests stable but non-growth team environment with focus on market maintenance rather than expansion.
alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. Phenylephrine possesses predominantly α-adrenergic effects. In the eye, phenylephrine acts locally as a potent vasoconstrictor and mydriatic, by constricting ophthalmic blood vessels…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluation of Efficacy and Safety of Tablets of Paracetamol, Dimethindene Maleate and Phenylephrine Hydrochloride in Reducing Symptoms of Common Cold and Flu
Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers
Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Worked on PHENYLEPHRINE HYDROCHLORIDE at Aspiro Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on phenylephrine hydrochloride offers stable, predictable career progression within a mature ophthalmology franchise with minimal competitive disruption. This is ideal for professionals seeking operational excellence and market management experience rather than high-growth launch dynamics or innovative R&D.